Hvilken er prisen på Alimera Sciences, Inc. (ALIM)

Prisen på Alimera Sciences, Inc. (ALIM) er $5.54

Hva er markedsverdien på Alimera Sciences, Inc. (ALIM)

Markedsverdien på Alimera Sciences, Inc. (ALIM) er $38.76M

Alimera Sciences, Inc. (ALIM) Utestående Aksjer

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

År	Utestående aksjer	Endre
2026 (TTM)	54.38M	112.75%
2023	25.56M	265.33%
2022	7.00M	6.10%
2021	6.60M	28.86%
2020	5.12M	7.30%
2019	4.77M	-18.70%
2018	5.87M	31.37%
2017	4.47M	26.88%
2016	3.52M	18.80%
2015	2.96M	10.03%
2014	2.69M	27.93%
2013	2.11M	0.38%
2012	2.10M	0.29%
2011	2.09M	0.29%
2010	2.09M	1,961.13%
2009	101.16K	-6.28%
2008	107.93K	0.00%
2007	107.93K	0.00%
2006	107.93K	0.00%

År

Utestående aksjer

Endre

2026 (TTM)

54.38M

112.75%

2023

25.56M

265.33%

2022

7.00M

6.10%

2021

6.60M

28.86%

2020

5.12M

7.30%

2019

4.77M

-18.70%

2018

5.87M

31.37%

2017

4.47M

26.88%

2016

3.52M

18.80%

2015

2.96M

10.03%

2014

2.69M

27.93%

2013

2.11M

0.38%

2012

2.10M

0.29%

2011

2.09M

0.29%

2010

2.09M

1,961.13%

2009

101.16K

-6.28%

2008

107.93K

0.00%

2007

107.93K

0.00%

2006

107.93K

0.00%

Selskap	Utestående aksjer	Forskjell	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	2.40B	4,311.84%	IN

Selskap

Utestående aksjer

Forskjell

Land